David A Candito

Years Active: 2021-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

David A Candito, Vladimir Simov, Anmol Gulati, Solomon D Kattar, Ryan W Chau, Blair T Lapointe, Joey L Methot, Duane E DeMong, Thomas H Graham, Ravi Kurukulasuriya, Mitchell H Keylor, Ling Tong, Gregori J Morriello, John J Acton, Barbara Pio, Weiguo Liu, Jack D Scott, Michael J Ardolino, Theodore A Martinot, Matthew L Maddess, Xin Yan, Hakan Gunaydin, Rachel L Palte, Spencer E McMinn, Lisa Nogle, Hongshi Yu, Ellen C Minnihan, Charles A Lesburg, Ping Liu, Jing Su, Laxminarayan G Hegde, Lily Y Moy, Janice D Woodhouse, Robert Faltus, Tina Xiong, Paul Ciaccio, Jennifer A Piesvaux, Karin M Otte, Matthew E Kennedy, David Jonathan Bennett, Erin F DiMauro, Matthew J Fell, Santhosh Neelamkavil, Harold B Wood, Peter H Fuller, J Michael Ellis
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1 H -Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease. Journal of medicinal chemistry (2022)
David A Candito, Yingchun Ye, Ryan V Quiroz, Michael H Reutershan, David Witter, Surendra B Gadamsetty, Hongming Li, Josep Saurí, Sebastian E Schneider, Colin Yu-Hong Lam, Rachel L Palte
Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-b]furan Nucleoside Analogues. The Journal of organic chemistry 86 (7) (2021)

David A Candito.css-eqlu8i{font-size:small;padding-left:4px;}